左乳腺癌改良根治术后调强放疗患者深度吸气屏气选择标准与方法
本研究纳入23例接受深度吸气屏气(DIBH)的左乳腺癌患者比较自由呼吸(FB)与DIBH计划,以FB平均心脏剂量4 Gy为阈值分组比较剂量差异与DIBH获益;另纳入30例仅FB患者分析心脏至胸壁欧氏距离(CCED)等解剖指标预测高心脏剂量风险的能力。结果显示4 Gy可作为选择DIBH的有效剂量阈值,CCED曲线下面积0.83,最佳截断值2.5 mm时灵敏度95%、特异度70%。
要点
- FB平均心脏剂量4 Gy可作为选择左乳腺癌改良根治术后DIBH患者的有效剂量阈值。
- FB平均心脏剂量≥4 Gy组的心脏剂量、心脏死亡正常组织并发症概率及DIBH获益均显著高于<4 Gy组。
- CCED是有效的解剖指标,最佳截断值2.5 mm时曲线下面积0.83、灵敏度95%、特异度70%。
核心结论
- 自由呼吸平均心脏剂量4 Gy可作为选择适合深度吸气屏气患者的有效剂量阈值。
- CCED可能有助于在CT模拟定位时可靠预测左乳腺癌患者的自由呼吸平均心脏剂量。
研究设计与样本
- 纳入23例接受DIBH治疗的左乳腺癌患者,比较自由呼吸与DIBH计划,并按自由呼吸平均心脏剂量≥4 Gy(高风险组)与<4 Gy(低风险组)分组比较剂量差异、正常组织并发症概率及DIBH获益。
- 另纳入30例仅行自由呼吸的患者,分析CCED、心脏至胸壁间隙(CCG)及心脏至胸壁组合(CCC)等解剖指标区分高心脏剂量风险患者的能力。
主要发现
- DIBH计划组所有心脏剂量均显著低于自由呼吸计划组。
- 以自由呼吸平均心脏剂量4 Gy为截断值,高风险组的心脏剂量、心脏死亡正常组织并发症概率及DIBH获益均显著高于低风险组。
- CCED是有效的解剖指标,曲线下面积最大为0.83,最佳截断值2.5 mm时保持95%灵敏度和70%特异度。
关键数值与推荐
- 自由呼吸平均心脏剂量4 Gy用作选择适合DIBH患者的剂量阈值。
- CCED最佳截断值为2.5 mm,此时曲线下面积0.83、灵敏度95%、特异度70%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study explored whether a free-breathing mean heart dose (FB-MHD) of 4 Gy is a reliable dose threshold for selecting left breast cancer patients after modified radical mastectomy suitable for deep inspiration breath-hold (DIBH) and developed anatomical indicators to predict FB-MHD for rapid selection. MATERIALS AND METHODS: Twenty-three patients with left breast cancer treated with DIBH were included to compare FB and DIBH plans. The patients were divided into the high-risk (FB-MHD ≥ 4 Gy) and low-risk (FB-MHD < 4 Gy) groups to compare dose difference, normal tissue complication probability (NTCP) and the DIBH benefits. Another 30 patients with FB only were included to analyze the capacity of distinguishing high-risk heart doses patients according to anatomical metrics, such as cardiac-to-chest Euclidean distance (CCED), cardiac-to-chest gap (CCG), and cardiac-to-chest combination (CCC). RESULTS: All heart doses were significantly lower in patients with DIBH plans than in those with FB plans. Based on FB-MHD of 4 Gy cutoff, the heart dose, NTCP for cardiac death, and benefits from DIBH were significantly higher in the high-risk group than in the low-risk group. The CCED was a valid anatomical indicator with the largest area under the curve (AUC) of 0.83 and maintained 95 % sensitivity and 70 % specificity at the optimal cutoff value of 2.5 mm. CONCLUSIONS: An FB-MHD of 4 Gy could be used as an efficient dose threshold for selecting patients suitable for DIBH. The CCED may allow a reliable prediction of FB-MHD in left breast cancer patients at CT simulation.
引用
- Zhou Y, Xu J, Xu F, et al. Selection criteria and method for deep inspiration breath-hold in patients with left breast cancer undergoing PMRT/IMRT. Clin Transl Radiat Oncol. 2024. PMID: 39044781. doi:10.1016/j.ctro.2024.100812
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。